# LevetIracetam in Patients Being Treated for Epilepsy

> **NCT02356731** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 450 (actual)

## Conditions studied

- Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02356731
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356731, "LevetIracetam in Patients Being Treated for Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02356731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*